| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.22 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |